RIATROPINE 0.5% Price

Overview

Welcome to Dwaey, specifically on RIATROPINE 0.5% Eye Drops page.
This medicine contains an important and useful components, as it consists of Atropine sulfate.
RIATROPINE 0.5% is available in the market in concentration 5mg/ml and in the form of Eye Drops.

RIYADH PHARMA (MEDICAL AND COSMETIC PRODUCTS COMPANY LTD.) is the producer of RIATROPINE 0.5% and it is imported from SAUDI ARABIA, The most popular alternatives of RIATROPINE 0.5% are listed downward .

Mode Of Action

Atropine is an anticholinergic agent which competitively blocks the muscarinic receptors in peripheral tissues such as the heart, intestines, bronchial muscles, iris and secretory glands. Some central stimulation may occur. Atropine abolishes bradycardia and reduces heart block due to vagal activity. Smooth muscles in the bronchi and gut are relaxed while glandular secretions are reduced. It also has mydriatic and cycloplegic effect.

Indication

• Bradycardia
• Organophosphorus poisoning
• Anesthesia adjunct

Precaution

Reflux oesophagitis, elderly, infants and children. Pregnancy. Lactation: Trace amounts enter breast milk; use with caution (AAP Committee states "compatible with nursing")

Side Effects

• Dry mouth
• dysphagia
• constipation
• flushing and dryness of skin
• tachycardia
• palpitations
• arrhythmias
• mydriasis
• photophobia
• cycloplegia
• raised intraocular pressure. Toxic doses cause tachycardia
• hyperpyrexia
• restlessness
• confusion
• excitement
• hallucinations
• delirium and may progress to circulatory failure and resp depression. Inhalation: Dryness of mouth
• throat. Potentially Fatal: Atrial arrhythmias
• AV dissociation
• multiple ventricular ectopics.

Contra indication

Glaucoma, chronic respiratory disease, sick sinus syndrome, thyrotoxicosis, cardiac failure, pyloric stenosis, prostatic hypertrophy.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks